A phase I study of ombrabulin (O) combined with bevacizumab (B) in patients with advanced solid tumors

Authors
Category Primary study
JournalJournal of Clinical Oncology
Year 2013
This article has no abstract
Epistemonikos ID: 46022b2054da64e9de44b45ea6c50a10f739a7dd
First added on: Feb 05, 2025